Mount Yale Investment Advisors, LLC Catalent, Inc. Transaction History

Mount Yale Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$87.2 - $114.05 $430,157 - $562,608	-4,933 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$94.19 - $124.49 $141,850 - $187,481	1,506 Added 43.95%	4,933 $547,000
Q4 2021 Feb 02, 2022	SELL	$119.57 - $139.07 $17,935 - $20,860	-150 Reduced 4.19%	3,427 $439,000
Q3 2021 Nov 02, 2021	BUY	$109.17 - $142.35 $390,501 - $509,185	3,577 New	3,577 $476,000
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $1,407 - $2,177	-47 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$40.12 - $45.55 $33,660 - $38,216	-839 Reduced 94.7%	47 $2,000
Q2 2018 Aug 22, 2018	SELL	$38.72 - $42.52 $77 - $85	-2 Reduced 0.23%	886 $37,000
Q1 2018 Jun 25, 2018	BUY	$39.4 - $47.39 $34,987 - $42,082	888 New	888 $36,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.